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Abstract: A case of sporadic Burkitt lymphoma (sBL) presenting with jaw and lid involvement 
in a diabetic adult African American female and a review of adult orbital Burkitt lymphoma cases 
are presented. Lid edema, visual loss, ophthalmoparesis, proptosis, and sinusitis progressed over 
4 weeks despite antibiotic and steroid treatment. Upper lid biopsy histopathological evaluation 
and immunophenotyping revealed a homogenous mass of atypical CD10 and CD20-negative 
B-cells and tingible body macrophages yielding a “starry sky” appearance. Cytogenetic analysis 
detected a minor variant c-MYC translocation, but no Epstein–Barr virus RNA. Detection 
of multiple lesions prompted a diagnosis of stage IV disease that totally regressed following 
radiation and chemotherapy. Review results of the six adult orbital sBL cases support a poor 
prognosis and a heightened suspicion of variant CD10, CD20 and BCL6 positive sBL in adults 
presenting with jaw pain and rapidly progressive orbital symptoms, particularly in female, 
African American, and diabetic patients.
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Introduction
Over 50 years ago Denis Burkitt described a monoclonal lymphoreticular cell tumor 
that bears his name.1–3 His contributions led to the discovery of the Epstein-Barr virus 
(EBV; human lymphotropic herpes virus),4 EBV’s relationship to Burkitt lymphoma 
(BL) and other lymphomas, and other oncogenic viruses.5,6 BL, originally described as 
a jaw mass seen in male children residing in equatorial Africa,1,2 commonly presents 
with extralymphnodal lesions; usually in the abdomen, mediastinum, spinal cord, 
gonads, orbit, salivary glands, urogenital tract, and/or bone marrow. BL is composed 
of malignant noncleaved B-lymphocytes and is highly aggressive with a doubling time 
of about 24 hours.7,8 BL occurs in all age and racial groups throughout the world.9–13
Three subtypes of BL are described based upon their epidemiological   distribution: 
endemic (eBL); sporadic (sBL); and immunodeficiency-associated (i-aBL). All BL 
subtypes share morphological, growth, and immunophenotypic characteristics and a 
nonrandom genetic heterogeneity.14,15 That is, BL arises due to reciprocal chromosomal 
translocations of the c-MYC proto-oncogene with different immunoglobulin heavy 
chain (IGH) genes resulting in c-MYC gene overexpression leading to   monoclonal 
expansion of immature B cells.15,16 Several other chromosomal abnormalities are 
  present in BL from EBV-positive children, but their roles are unknown.14,17,18 Endemic 
BL usually presents in EBV-seropositive children as an extranodal tumor usually 
involving the jaw and soft tissues of the orbit and abdomen in male children and 
young adults that reside in high-incidence (  malnutrition, EBV and malaria   infestation) Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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zones of equatorial Africa and South America (50–100 
cases/  million/year).1,2,9,11,12,19   Pediatric and adult sBL cases 
occur worldwide in countries outside the equatorial zone 
and commonly present with tumor involvement.9,12,13,19 The 
  incidence of sBL in the United States is 2–3 cases/million/
year.9 Sporadic BL accounts for 30%–50% of lymphomas 
in children, but only 1%–2% of lymphomas in adults.11,20,21 
In contrast to eBL, sBL rarely presents as orbital disease 
in United States children.22,23 Immunodeficiency-associated 
BL occurs in immunocompromised patients, such as AIDS 
patients and organ transplant recipients. Immunodeficiency-
associated BL accounts for 20%–35% of lymphomas in 
pediatric and adult AIDS cases and the clinical features 
are similar to those of sBL, except for a much higher initial 
involvement of the central nervous system (CNS).16,21,24–28 
c-MYC rearrangements and EBV infection are detectable 
in 20%–40% of HIV-associated cases.29 In AIDS-associated 
i-aBL, defective regulation of EBV-infection is thought 
to give rise to uncontrolled B-cell differentiation.30 A BL 
variant of post-transplant lymphoproliferative disorder 
(PTLD) can occur in solid organ transplant recipients who 
receive long-term immunosuppressive therapy and is usu-
ally characterized by weight loss, fever, and generalized 
lymphadenopathy with bone marrow involvement,31–33 
c-MYC rearrangement and type A EBV infection in .80% 
of cases.32–34 In PTLD patients, the interaction of the latent 
EBV nuclear antigen with the BCL2 gene prevents apoptosis 
and promotes B-cell immortalization.17
Lymphomas of the ocular adnexa represent 8%–11% of all 
extranodal lymphoid tumors.20,35–37 The sporadic form of BL 
occurs primarily in “older” American adults (most .40 years 
old).9 Orbital involvement as the presenting symptom in 
adult sBL is rare; PubMed and OVID electronic searches 
identified five adult orbital sBL cases.38–41 Herein we report 
a case of orbital sBL in an African American female adult 
who presented with jaw pain, lid edema, and new onset dia-
betes mellitus (DM) and briefly review the adult orbital sBL 
cases. Orbital sBL symptoms may   masquerade initially as an 
  infection (cellulitis) or inflammatory pseudotumor delaying 
diagnosis, staging and appropriate therapy. Our results support 
a heightened suspicion of sBL in adults presenting with jaw 
pain and rapidly progressive orbital symptoms, particularly 
in female, African American, and diabetic patients.
Case report
A 49-year-old African American female presented to a 
local dentist in late December with right-side tooth pain. 
The dentist empirically prescribed Cefadroxil and Loritab 
based upon a negative X-ray of the right jaw and advised 
her to seek emergency care if symptoms worsened. Four 
days later, she presented at a local Emergency Room and 
was admitted to our hospital with complaints of right-
side “teeth pain”, numbness of upper and lower lips, and 
edema of upper eyelid. Her past medical history was 
significant for penicillin and sulfa allergies, foot surgery 
and a hysterectomy. The patient’s consultant ophthalmic 
evaluation revealed a best corrected visual acuity of 20/30 
OD and 2+ to 3+ upper eyelid edema that was not warm 
or tender to touch. She had normal extraocular movement, 
pupillary reactions, intraocular pressures and ocular fundi 
of the affected and fellow eyes. No other ocular symptoms 
were noted. Computed tomography (CT) scans of the orbit 
revealed extensive soft tissue swelling in the right paraseptal 
orbit and mucosal thickening in the right frontal and 
maxillary sinuses, and right anterior and medial ethmoidal 
cells (Figure 1A) consistent with a presumptive diagnosis 
of preseptal cellulitis. The patient received a 5-day course 
of intravenous antibiotics (Vancomycin and Clindamycin) 
with improvement in jaw pain, but only slight improvement 
AB
CD
Figure 1 A) Axial computed tomography (CT) scan showing extensive soft tissue 
swelling and mucosal thickening of right ethmoidal sinus (*). B) Axial CT scan (6 days 
after the first CT scan) showing increased enlargement of the extraconal soft tissue 
mass in the right orbital roof with inferior displacement of the globe. Note the 
marked proptosis and “banjo-string” deformation of the optic nerve (arrowhead) 
and increased mucosal thickening in the right maxillary and frontal sinuses (asterisks 
in scans). C) Coronal reconstruction view (6 days after the first CT scan) supported 
extension of the soft tissue mass in the superior lateral right orbit (arrowhead) as well 
as ethmoid sinusitis (*). D) Axial CT scan shows normal ocular presentation with no 
evidence of tumor in the orbit or sinus at 21 months post-initiation of treatment.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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in orbital symptoms. Her clinical work-up was significant 
for hypertension and new onset diabetes. Accordingly, the 
patient’s comprehensive metabolic panel was significant 
for elevated glucose in plasma (273 to 321 mg/dL) and 
urine (1000 mg/dL), as well as slightly elevated ketones 
(5 mg/dL) in her urine. Her CBC was significant for elevated 
erythrocytes (5.25 million/µL) and hemaglobin (15.6 g/dL). 
She was discharged on hypertension and DM control 
medications, diabetic diet, prednisone (40 mg/day for 1 day, 
then 20 mg/day for 3 days) for treatment of the suspected 
noninfectious pseudotumor. She was given a follow-up eye 
clinic appointment (1 week) and instructed to return sooner 
if symptoms worsened.
The patient presented to the LSUHSC Eye Clinic six 
days later with complaints of progressive lid edema and 
proptosis. An external eye examination revealed decreased 
vision (20/60 OD), restricted extraocular motion (-2 in up 
gaze/down gaze, -1 in right/left gaze), 3+ edema of right 
upper eyelid (not warm or tender-to-touch), and conjunctival 
chemosis. CT scans revealed increased swelling of soft tis-
sue of the right lid, mucosal thickening of right frontal and 
maxillary sinuses, and proptosis (Figure 1B). Comparison of 
CT scans confirmed an aggressively expanding extraconal 
mass undifferentiated from the lacrimal glands, causing a 
stretched optic nerve yielding a “banjo string” sign, and 
downward displacement of the globe (Figure 1C).
The patient consented to a right upper lid biopsy, and 
it was performed on day 21 after initial presentation. The 
histopathological evaluation revealed a homogenous mass 
infiltrating the soft orbital tissue (Figure 2A) composed 
of medium sized noncleaved cells with nuclei containing 
multiple nucleoli and a thin rim of basophilic   cytoplasm. Also, 
the mass contained scattered histiocytic cells   (macrophages 
containing phagocytized cellular debris)   yielding a 
“starry sky” pattern consistent with a   lymphoproliferative 
disorder, possibly high-grade lymphoma (Figure 2B). 
Immunophenotyping and cytogenetic analyses supported 
a diagnosis of BL. Immunohistochemistry of the biopsied 
tissue showed positive staining for CD19, CD22, CD24, 
CD30, CD79A (immunoglobulin-associated α antigen), 
and cytoplasmic κ-light chain, but negative staining for 
CD3, CD10, CD20, BCL11, BCL14, and TdT. Cytogenetic 
evaluation using fluorescence in situ hybridization 
(FISH) probes designed to detect the most frequently 
observed translocation t(8;14) (involving MYC region 
at 8Q24 and IGH at 14Q32) was negative, but using a 
mixture of two probes that detect other variant MYC 
translocations revealed a c-MYC rearrangement consistent 
with a minor variant MYC translocation at either t(8;22) 
or t(2;8).14–16 The patient’s BL did not contain detectable 
EBV RNA. Flow cytometry demonstrated monoclonal 
B-cell expansion consistent with BL. The patient’s serum 
lactate dehydrogenase (LDH) was elevated at 826 IU/dL. 
The patient’s systemic work-up included a proton emission 
tomography (PET) scan, performed on day 24 post onset 
of symptoms, that revealed a systemic disease process with 
bone involvement of the mid and upper thoracic spines and 
brain. Lumbar puncture and bone marrow aspirates were 
negative for BL cells. Concomitantly, CT scans of the chest, 
abdomen and pelvis revealed subcentimeter axillary nodes, 
small soft tissue lesions involving thoracic vertebrae and 
thoracic descending aorta, small bilateral focal renal lesions 
and heterogeneous abnormalities in the presacral region and 
right lateral wall of urinary bladder.
Our patient received a 4-week course of daily radiation 
therapy and underwent placement of an Omaya reservoir in the 
ventricular system of the brain 1 week into the radiation therapy 
to facilitate intrathecal chemotherapy. Her chemotherapy 
regime included four cycles of high dose cyclophosphamide, 
intrathecal methotrexate and cytarabine. After 10 months of 
radiation and chemotherapy treatment, CT scans showed 
complete resolution of the ocular disease (Figure 1D). The 
patient is in remission with full ocular function at 5 years 
after treatment. The LSUHSC IRB/Ethics Committee ruled 
that approval was not required for this study.
Discussion
The presenting symptoms of jaw pain and orbital involvement 
in our 49-year-old diabetic African American female patient 
are commonly observed in African children with eBL. That 
AB
Figure 2 A) Histopathology of the lid biopsy tissue showing inflammation and 
invasion of the lid tissue by large lymphocytes. B) High power magnification of the 
biopsy revealing the typical appearance of BL characterized by the tightly packed 
proliferative  neoplastic  lymphocytes  (*)  with  high  nuclear-to-cytoplasmic  ratios 
interspersed with histiocytic cells (large tingible body macrophages) containing dead 
cell debris (arrows) yielding a “starry sky” appearance (ie, stars in a sky of B cells). 
(H&e; 400×).Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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is, about 65% of African children with eBL present with 
concurrent jaw and orbital symptoms.11 Our case is the second 
adult sBL patient to present with jaw and facial symptoms.41 
Only six confirmed adult orbital sBL cases (average age 
of 61 ± 22 years; range 24 to 84 years) are reported in the 
literature to date (Table 1). Half or more of the adult orbital 
sBL patients are aged $40 years and presented with or 
developed facial swelling, orbital edema, loss of vision, 
proptosis, restricted ocular motility, chemosis, and sinus 
involvement. Notably, 66% (2 of 3) of the African American 
adult orbital sBL cases presented with facial pain, orbital 
edema, proptosis, and sinus involvement. Comparison of 
the reported adult sBL cases indicates females are affected 
more often than males (2:1), but did not reveal a race or 
eye predilection. The 3 African American, 2 Caucasian 
and 1 Chinese adult orbital sBL presented with an equal 
distribution between left and right eyes (3:3).
Misdiagnosis of orbital sBL is common due to the rare 
presentation of ocular involvement. As in our case and most 
of the previously reported adult sBL cases,38–41 making the 
correct diagnosis can be difficult; the process being one 
of exclusion. Accordingly, most of the adult sBL patients 
received antibiotics and/or steroids initially for suspected 
infectious and inflammatory diseases with transient or no 
improvement. The progressive growth over a 2-week period 
was highly suggestive of BL and consistent with the rapid 
growth observed in most lymphomas.7–9,19,36–38 Once BL was 
suspected, PET and CT scans revealed multiple systemic BL 
lesions consistent with a stage IV disease. Most of the adult 
orbital sBL patients (4 of 6) had multiple extranodal lesions 
in bone marrow, brain, heart, chest, abdomen,   pelvis, and/or 
groin, but two patients had orbital lesions only (Table 1). Since 
88% (14 of 16) of the adult orbital BL patients had systemic 
involvement,41 it is recommended that all suspected adult 
orbital BL patients be given emergent systemic evaluations. 
Regression of our patient’s BL with complete recovery 
of vision occurred following combination treatment with 
radiation, intrathecal and standard systemic chemotherapy.41 
Review of the adult orbital sBL case outcomes revealed death 
and/or persistent lesions in 83% (5 of 6) of patients at 1 year; 
three of the six patients died within 10 months of the initial 
diagnosis, two patients had total regression of the orbital 
lesion but systemic BL persisted, while our patient remains 
free of BL after 5 years (Table 1). These results are consistent 
with the high mortality reported in older BL patients,41 but 
firm numbers are not available since few therapeutic trials 
include BL patients aged over 60 years. Several factors may 
be responsible for the high mortality. The treatment response 
appears to vary with age, extent of disease (especially 
CNS involvement), immunophenotype and translocation 
genotype.33,35,38,41 Further, i-aBL patients generally require 
modifications of radiation and chemotherapy.16,19,33 Safe 
and effective antiviral and immuno-therapies to prevent 
EBV latency and EBV-associated lymphomas are under 
investigation.42
A diagnosis of BL is confirmed by tumor histopathological 
examination and immunophenotyping. The histopathological 
examinations of our patient’s lid biopsy revealed a mass 
of noncleaved lymphocytic cells with scattered tingible 
body macrophages containing phagocytized cellular 
debris yielding a “starry sky” appearance. Evaluations of 
all tissue biopsies from the adult orbital BL cases yielded 
histopathological findings consistent with a diagnosis of BL 
(Table 1). The histopathology descriptions of four of the six 
adult sBL tumor biopsies noted a “starry sky” appearance. 
The classical BL immunophenotypic profile includes   
B-cell markers CD10, CD20, CD21 (common to endemic 
BL), CD79a, BCL-6 (downregulation of BCL6 required for 
plasmacyte differentiation)43 and IgM, but not CD5, CD23, 
TdT and BCL-20.7,11,32,36 A comparison of immunophenotype 
profiles of five adult orbital sBL cases revealed 80% (4 of 5 
cases) expressed B-cell markers CD10 and CD20, 60% (3 of 
5) expressed BCL6 (B-cell CLL/lymphoma), 40% (2 of 5) 
expressed CD79A (immunoglobulin-associated alpha), and 
40% (2 of 5) expressed Ki67. Immunophenotypic analysis 
of our patient’s biopsied tissue showed positive staining for 
BL cell markers CD19, CD22, CD24, CD30, and CD79a. 
Our patient’s BL did not react with CD10 (common acute 
leukemia/lymphoma antigen) or CD20 (membrane spanning 
domain antigen). Decreased CD20 expression is common 
to some high-grade aggressive B-cell lymphomas with 
translocations involving c-MYC and BCL6.44
Review of the adult orbital sBL cases revealed 50% (3 of 
6) of the patients had DM and 67% (2 of 3) of the diabetic 
orbital sBL expressed BCL6 (Table 1). The high incidence 
of orbital sBL associated with DM suggests a theoretical 
association. Although an increased incidence of several 
cancers has been observed in diabetic patients45,46 and a role 
for ketone and lactate in tumor growth and metastasis has been 
postulated recently,47 an epidemiologic basis or molecular 
mechanism for an association between human EBV infection, 
orbital sBL and diabetes lacks direct support at present. It is 
noteworthy that increased diabetes susceptibility and diabetic 
autoimmune disease in experimental animal models are 
associated with altered BCL genes.48,49 Concomitantly, the 
EBV load is slightly higher in type 1 DM patients than in Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
513
Orbital Burkitt lymphoma in a diabetic adult
T
a
b
l
e
 
1
 
r
e
v
i
e
w
 
o
f
 
t
h
e
 
d
o
c
u
m
e
n
t
e
d
 
c
a
s
e
s
 
o
f
 
a
d
u
l
t
 
s
p
o
r
a
d
i
c
 
B
u
r
k
i
t
t
 
l
y
m
p
h
o
m
a
 
p
r
e
s
e
n
t
i
n
g
 
a
s
 
a
n
 
o
r
b
i
t
a
l
 
m
a
s
s
C
a
s
e
s
I
n
i
t
i
a
l
 
 
d
i
a
g
n
o
s
i
s
/
T
x
P
r
e
s
e
n
t
i
n
g
 
o
c
u
l
a
r
 
s
i
g
n
 
a
n
d
 
s
y
m
p
t
o
m
s
H
i
s
t
o
p
a
t
h
o
l
o
g
y
 
a
n
d
/
o
r
 
I
m
m
u
n
o
p
h
e
n
o
t
y
p
e
C
y
t
o
g
e
n
e
t
i
c
 
 
e
v
a
l
u
a
t
i
o
n
E
B
V
 
 
s
t
a
t
u
s
S
y
s
t
e
m
i
c
 
d
i
s
e
a
s
e
 
 
(
S
t
a
g
e
)
S
u
r
v
i
v
a
l
2
4
-
y
e
a
r
-
o
l
d
 
 
C
h
i
n
e
s
e
 
m
a
l
e
3
8
O
r
b
i
t
a
l
 
 
i
n
fl
a
m
m
a
t
o
r
y
 
 
d
i
s
e
a
s
e
;
 
 
s
t
e
r
o
i
d
 
T
x
O
n
e
 
d
a
y
 
p
a
i
n
f
u
l
 
l
i
d
 
s
w
e
l
l
i
n
g
 
O
s
,
 
d
e
c
r
e
a
s
e
d
 
 
V
A
 
(
2
0
/
8
0
)
,
 
n
o
n
a
x
i
a
l
 
p
r
o
p
t
o
s
i
s
,
 
c
h
e
m
o
s
i
s
,
 
r
O
M
.
 
C
T
 
s
c
a
n
 
s
h
o
w
e
d
 
s
o
f
t
 
t
i
s
s
u
e
 
m
a
s
s
 
i
n
 
 
t
h
e
 
s
u
p
e
r
i
o
r
,
 
p
o
s
t
e
r
i
o
r
 
a
n
d
 
l
a
t
e
r
a
l
 
a
s
p
e
c
t
s
 
 
o
f
 
t
h
e
 
o
r
b
i
t
.
H
i
s
t
o
p
a
t
h
o
l
o
g
y
 
o
f
 
b
i
o
p
s
y
 
 
a
n
d
 
b
o
n
e
 
m
a
r
r
o
w
 
a
s
p
i
r
a
t
e
 
 
c
o
n
s
i
s
t
e
n
t
 
w
i
t
h
 
B
L
N
D
N
D
I
n
c
r
e
a
s
e
d
 
W
B
C
;
 
 
B
M
D
i
e
d
 
2
2
 
w
e
e
k
s
 
p
o
s
t
 
o
n
s
e
t
6
3
-
y
e
a
r
-
o
l
d
 
D
i
a
b
e
t
i
c
 
 
B
l
a
c
k
 
f
e
m
a
l
e
4
1
N
a
u
s
e
a
,
 
 
a
b
d
o
m
i
n
a
l
 
p
a
i
n
 
 
a
n
d
 
d
i
s
t
e
n
t
i
o
n
;
 
 
1
 
w
k
 
e
y
e
 
p
a
i
n
/
 
e
d
e
m
a
 
 
s
u
r
g
e
r
y
 
T
x
O
n
e
 
w
e
e
k
 
H
x
 
o
f
 
p
r
o
g
r
e
s
s
i
v
e
 
O
D
 
e
y
e
 
p
a
i
n
,
 
r
e
d
n
e
s
s
,
 
v
i
s
i
o
n
 
l
o
s
s
,
 
s
w
o
l
l
e
n
 
l
i
d
s
;
 
O
D
 
V
A
 
 
h
a
n
d
 
m
o
t
i
o
n
,
 
r
i
g
h
t
 
a
f
f
e
r
e
n
t
 
p
u
p
i
l
l
a
r
y
 
d
e
f
e
c
t
 
O
D
,
 
3
6
0
°
 
r
O
M
,
 
p
t
o
s
i
s
,
 
l
i
d
 
e
d
e
m
a
,
 
c
h
e
m
o
s
i
s
,
 
p
r
o
p
t
o
s
i
s
,
 
e
l
e
v
a
t
e
d
 
I
O
P
;
 
C
T
 
s
c
a
n
 
s
h
o
w
e
d
 
 
O
D
 
d
i
f
f
u
s
e
 
o
r
b
i
t
a
l
 
i
n
fi
l
t
r
a
t
e
,
 
e
t
h
m
o
i
d
 
s
i
n
u
s
 
 
d
i
s
e
a
s
e
/
a
d
j
a
c
e
n
t
 
b
o
n
e
 
e
r
o
s
i
o
n
.
H
x
:
 
“
s
t
a
r
r
y
 
s
k
y
”
 
a
p
p
e
a
r
a
n
c
e
,
 
 
m
e
d
i
u
m
 
s
i
z
e
d
 
a
t
y
p
i
c
a
l
 
 
l
y
m
p
h
o
c
y
t
e
s
;
 
B
 
c
e
l
l
 
m
a
r
k
e
r
s
;
 
 
C
D
1
0
,
 
C
D
2
0
,
 
C
D
4
5
 
a
n
d
 
 
B
C
L
6
;
 
K
i
-
6
7
N
o
t
 
s
p
e
c
i
fi
c
 
f
o
r
 
B
L
N
D
C
T
 
r
e
v
e
a
l
e
d
 
l
e
s
i
o
n
s
 
 
i
n
 
s
p
l
e
e
n
 
a
n
d
 
l
e
f
t
 
g
r
o
i
n
F
i
v
e
 
m
o
n
t
h
s
 
a
f
t
e
r
 
i
n
i
t
i
a
l
 
p
r
e
s
e
n
t
a
t
i
o
n
,
 
t
h
e
 
p
a
t
i
e
n
t
 
p
r
e
s
e
n
t
e
d
 
w
i
t
h
 
f
e
v
e
r
 
a
n
d
 
i
n
f
e
c
t
i
o
n
.
 
C
O
D
;
 
s
e
p
s
i
s
7
2
-
y
e
a
r
-
o
l
d
 
 
B
l
a
c
k
 
m
a
l
e
4
1
P
o
s
s
i
b
l
e
 
 
i
n
f
e
c
t
i
o
n
;
 
 
A
n
t
i
b
i
o
t
i
c
 
T
x
T
w
o
 
w
e
e
k
s
 
t
o
o
t
h
 
p
a
i
n
 
a
n
d
 
m
i
d
f
a
c
i
a
l
 
s
w
e
l
l
i
n
g
;
 
F
o
r
 
1
 
w
e
e
k
,
 
P
r
o
g
r
e
s
s
i
v
e
 
O
D
 
e
y
e
 
p
r
o
p
t
o
s
i
s
,
 
c
h
e
m
o
s
i
s
,
 
O
D
 
V
A
 
c
o
u
n
t
 
fi
n
g
e
r
 
a
t
 
5
 
f
e
e
t
,
 
3
6
0
°
 
r
O
M
,
 
c
h
e
m
o
s
i
s
,
 
e
l
e
v
a
t
e
d
 
I
O
P
;
 
C
T
 
s
c
a
n
 
r
e
v
e
a
l
e
d
 
l
a
r
g
e
 
m
a
s
s
 
i
n
 
i
n
f
e
r
i
o
r
 
o
r
b
i
t
 
a
n
d
 
s
u
p
e
r
i
o
r
 
m
a
x
i
l
l
a
r
y
 
s
i
n
u
s
 
w
i
t
h
 
b
o
n
e
 
e
r
o
s
i
o
n
.
H
x
:
 
“
s
t
a
r
r
y
 
s
k
y
”
 
a
p
p
e
a
r
a
n
c
e
.
 
 
B
 
c
e
l
l
 
m
a
r
k
e
r
s
;
 
C
D
1
0
,
 
 
C
D
2
0
,
 
a
n
d
 
B
C
L
6
,
 
K
i
-
6
7
;
 
 
H
i
g
h
 
M
i
t
o
t
i
c
 
I
n
d
e
x
I
G
H
 
r
e
a
r
r
a
n
g
e
m
e
n
t
;
 
 
c
-
M
Y
C
 
t
r
a
n
s
l
o
c
a
t
i
o
n
 
[
t
(
8
;
1
4
)
]
N
D
N
o
 
s
i
g
n
s
 
o
f
 
s
y
s
t
e
m
i
c
 
l
y
m
p
h
o
m
a
 
s
t
a
g
e
 
I
e
A
l
i
v
e
 
a
t
 
1
3
 
m
o
n
t
h
s
 
p
o
s
t
 
i
n
i
t
i
a
l
 
p
r
e
s
e
n
t
a
t
i
o
n
,
 
b
u
t
 
d
e
v
e
l
o
p
e
d
 
s
k
u
l
l
 
m
e
t
a
s
t
a
s
e
s
7
8
-
y
e
a
r
-
o
l
d
 
 
W
h
i
t
e
 
f
e
m
a
l
e
4
0
D
a
c
r
o
a
d
e
n
i
t
i
s
,
 
l
y
m
p
h
o
m
a
,
 
 
l
a
c
r
i
m
a
l
 
o
r
 
 
g
l
a
n
d
 
t
u
m
o
r
T
h
r
e
e
 
w
e
e
k
s
 
H
x
 
o
f
 
i
n
c
r
e
a
s
i
n
g
 
s
w
e
l
l
i
n
g
 
o
f
 
u
p
p
e
r
 
O
s
 
o
r
b
i
t
.
 
1
 
m
m
 
P
r
o
p
t
o
s
i
s
.
 
C
T
 
s
c
a
n
s
 
r
e
v
e
a
l
e
d
 
l
e
f
t
 
s
u
p
e
r
-
t
e
m
p
o
r
a
l
 
o
r
b
i
t
a
l
 
m
a
s
s
 
i
n
 
t
h
e
 
l
a
c
r
i
m
a
l
 
g
l
a
n
d
 
r
e
g
i
o
n
 
c
a
u
s
i
n
g
 
n
a
s
a
l
 
d
i
s
p
l
a
c
e
m
e
n
t
 
o
f
 
t
h
e
 
g
l
o
b
e
.
H
x
:
 
h
i
g
h
-
g
r
a
d
e
 
B
 
c
e
l
l
 
 
l
y
m
p
h
o
m
a
;
 
B
 
c
e
l
l
 
m
a
r
k
e
r
s
;
 
 
C
D
1
0
 
a
n
d
 
C
D
2
0
N
D
N
D
N
o
 
s
y
s
t
e
m
i
c
 
d
i
s
e
a
s
e
F
r
e
e
 
f
o
r
 
5
 
m
o
n
t
h
s
;
 
L
o
s
t
 
t
o
 
f
o
l
l
o
w
-
u
p
;
 
D
i
e
d
 
1
0
 
m
o
n
t
h
s
 
p
o
s
t
 
i
n
i
t
i
a
l
 
D
x
8
4
-
y
e
a
r
-
o
l
d
 
D
i
a
b
e
t
i
c
 
 
W
h
i
t
e
 
f
e
m
a
l
e
3
9
M
y
o
s
i
t
i
s
;
 
 
s
t
e
r
o
i
d
 
T
x
D
i
p
l
o
p
i
a
;
 
2
 
w
e
e
k
 
s
w
e
l
l
i
n
g
 
o
f
 
o
r
b
i
t
 
O
s
;
 
r
e
t
u
r
n
e
d
 
a
t
 
2
 
m
o
n
t
h
s
 
w
i
t
h
 
s
w
e
l
l
i
n
g
 
i
n
 
 
o
r
b
i
t
 
O
s
 
w
i
t
h
 
p
r
o
p
t
o
s
i
s
,
 
V
A
 
(
2
0
/
3
0
)
,
 
 
r
O
M
,
 
d
i
p
l
o
p
i
a
.
H
x
:
 
“
s
t
a
r
r
y
 
s
k
y
”
 
a
p
p
e
a
r
a
n
c
e
.
 
 
B
 
c
e
l
l
 
m
a
r
k
e
r
s
;
 
C
D
7
9
A
,
 
 
C
D
2
0
,
 
C
D
1
0
,
 
C
D
4
3
,
 
B
C
L
6
,
 
 
V
s
3
8
c
 
a
n
d
 
I
g
I
G
H
 
r
e
a
r
r
a
n
g
e
m
e
n
t
;
 
 
P
l
a
s
m
a
c
y
t
o
i
d
 
 
B
L
 
v
a
r
i
a
n
t
N
e
g
C
N
s
,
 
h
e
a
r
t
,
 
l
u
n
g
,
 
B
M
;
 
s
t
a
g
e
 
I
V
C
o
m
p
l
e
t
e
 
o
r
b
i
t
a
l
 
t
u
m
o
r
 
r
e
g
r
e
s
s
i
o
n
 
a
t
 
5
 
m
o
n
t
h
s
,
 
b
u
t
 
p
e
r
s
i
s
t
e
n
t
 
l
y
m
p
h
a
d
e
n
o
p
a
t
h
y
4
9
-
y
e
a
r
-
o
l
d
 
D
i
a
b
e
t
i
c
 
 
B
l
a
c
k
 
f
e
m
a
l
e
 
(
C
u
r
r
e
n
t
 
c
a
s
e
)
O
r
b
i
t
a
l
 
 
c
e
l
l
u
l
i
t
i
s
;
 
 
A
n
t
i
b
i
o
t
i
c
 
T
x
 
P
s
e
u
d
o
t
u
m
o
r
;
 
 
s
t
e
r
o
i
d
 
T
x
P
r
e
s
e
n
t
e
d
 
t
o
 
d
e
n
t
i
s
t
 
w
i
t
h
 
5
 
d
a
y
s
 
H
x
 
o
f
 
 
t
o
o
t
h
 
p
a
i
n
 
a
n
d
 
p
a
i
n
l
e
s
s
 
l
i
d
 
e
d
e
m
a
 
O
D
;
 
 
5
 
d
a
y
s
 
l
a
t
e
r
 
a
t
 
e
r
 
–
 
t
e
e
t
h
 
p
a
i
n
,
 
j
a
w
 
 
n
u
m
b
n
e
s
s
 
a
n
d
 
p
r
o
g
r
e
s
s
i
v
e
 
l
i
d
 
e
d
e
m
a
,
 
a
n
d
 
 
n
e
w
 
o
n
s
e
t
 
d
i
a
b
e
t
e
s
;
 
r
e
t
u
r
n
e
d
 
6
 
d
a
y
s
 
l
a
t
e
r
 
 
w
i
t
h
 
p
r
o
g
r
e
s
s
i
v
e
 
l
o
s
s
 
V
A
,
 
r
O
M
 
a
n
d
 
 
p
r
o
p
t
o
s
i
s
;
 
C
T
 
s
c
a
n
s
 
s
h
o
w
e
d
 
p
r
o
g
r
e
s
s
i
v
e
 
 
r
i
g
h
t
 
s
u
p
e
r
i
o
r
 
o
r
b
i
t
a
l
 
m
a
s
s
 
a
n
d
 
s
i
n
u
s
i
t
i
s
.
H
x
:
 
“
s
t
a
r
r
y
 
s
k
y
”
 
a
p
p
e
a
r
a
n
c
e
;
 
 
h
i
g
h
-
g
r
a
d
e
 
B
 
c
e
l
l
 
l
y
m
p
h
o
m
a
;
 
 
B
 
c
e
l
l
 
m
a
r
k
e
r
s
;
 
C
D
1
9
,
 
C
D
2
2
,
 
 
C
D
2
4
,
 
C
D
3
0
,
 
C
D
7
9
A
,
 
a
n
d
 
c
y
t
o
p
l
a
s
m
i
c
 
k
a
p
p
a
 
l
i
g
h
t
 
c
h
a
i
n
I
G
H
 
r
e
a
r
r
a
n
g
e
m
e
n
t
;
 
 
V
a
r
i
a
n
t
 
c
-
M
Y
C
 
 
t
r
a
n
s
l
o
c
a
t
i
o
n
 
 
[
e
i
t
h
e
r
 
t
(
8
;
2
2
)
 
 
o
r
 
t
(
8
;
2
)
]
N
e
g
C
N
s
,
 
s
p
i
n
e
,
 
c
h
e
s
t
,
 
 
a
b
d
o
m
e
n
,
 
p
e
l
v
i
s
,
 
h
e
a
r
t
,
 
k
i
d
n
e
y
,
 
u
r
i
n
a
r
y
 
b
l
a
d
d
e
r
.
 
e
l
e
v
a
t
e
d
 
L
D
H
 
s
t
a
g
e
 
I
V
A
l
i
v
e
,
 
5
 
y
e
a
r
s
 
p
o
s
t
 
D
x
 
w
i
t
h
 
n
o
r
m
a
l
 
o
c
u
l
a
r
 
f
u
n
c
t
i
o
n
A
b
b
r
e
v
i
a
t
i
o
n
s
:
 
T
x
,
 
t
r
e
a
t
m
e
n
t
;
 
H
x
,
 
h
i
s
t
o
r
y
;
 
D
x
,
 
d
i
a
g
n
o
s
i
s
;
 
V
A
,
 
v
i
s
u
a
l
 
a
c
u
i
t
y
;
 
r
O
M
,
 
r
e
s
t
r
i
c
t
e
d
 
o
c
u
l
a
r
 
m
o
t
i
l
i
t
y
;
 
C
T
,
 
c
o
m
p
u
t
e
d
 
t
o
m
o
g
r
a
p
h
y
;
 
W
B
C
,
 
w
h
i
t
e
 
b
l
o
o
d
 
c
o
u
n
t
;
 
B
M
,
 
b
o
n
e
 
m
a
r
r
o
w
;
 
L
D
H
,
 
l
a
c
t
o
s
e
 
d
e
h
y
d
r
o
g
e
n
a
s
e
;
 
C
O
D
,
 
c
a
u
s
e
 
o
f
 
d
e
a
t
h
;
 
N
D
,
 
n
o
t
 
d
o
n
e
.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
514
Carmody et al
non-DM patients.50 Further, EBV nuclear antigen can interact 
with BCL genes.51 A BCL6 translocation is suspected in 
our patient due to the reported association between c-MYC 
and BCL translocations and decreased CD20.44 However, 
BCL6 gene translocation or expression analyses were not 
obtained on our patient’s BL. Additional studies are needed 
to investigate EBV-associated cMYC and BCL translocations 
in adult diabetic patients with and without sBL. It should 
be noted that EBV infection and c-MYC translocations 
involving IGH and BCL genes are not exclusive to BL, being 
found in other B-cell lymphomas.19–21,36,44
Most BL (80%) have a translocation of the c-MYC 
proto-oncogene from chromosome 8 to the IGH gene region 
of chromosome 14b [t(8;14)] and most BL patients have a 
history of EBV infection. In fewer cases (15%–20%), the 
c-MYC gene is translocated to the κ-light chain loci on 
chromosome 2 [t(8;2)] or to the λ-light chain on chromosome 
22 [t(8;22)].14–16,18,19 FISH analysis of our patient’s orbital mass 
did not detect either of the classical translocations. FISH 
analysis using an alternate probe for segregation of c-MYC 
showed fission of the c-MYC locus and supported a minor 
variant translocation involving chromosome 2 or 22. While 
the detection of a c-MYC translocation strongly supports the 
diagnosis of BL, demonstration of a c-MYC rearrangement 
in the context of other clinico-pathologic findings in our 
patient is confirmatory. Cytogenetic evaluation identified 
c-MYC gene rearrangements involving IGH genes in 3 of 
4 adult orbital BL analyses, but the translocations appear to 
have involved different gene loci (Table 1). Interestingly, only 
one of the orbital sBL had a classical c-MYC translocation 
[t(8;14)].41 Moreover, comparisons of the cytogenetic results 
failed to identify a consensus IGH gene rearrangement 
involving the c-MYC gene in 4 adult orbital sBL. The failure 
to detect EBV RNA in our patient’s BL cells is consistent with 
the generally low frequency of EBV detection (25%–30%) in 
European and North/South American sBL cases.9 Similarly, 
EBV RNA was not detected in two adult orbital sBL cases 
(Table 1). In contrast, EBV is detected in 98% eBL, 30%–40% 
HIV-associated BL, and 80%–100% of the BL variant of 
PTLD.11,17,18,29,32
In summary, we present a rare case of adult orbital sBL 
that masqueraded initially as cellulitis/pseudotumor, but 
responded to radiation and chemotherapy once   correctly 
diagnosed. The results of the review of the six adult 
orbital sBL cases was remarkable for 2:1 female-to-male 
  predilection; a history of diabetes; B-cells expressing CD10, 
CD20 and BCL6; and an initial clinical presentation of jaw 
and orbital symptoms in adult African Americans.
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